• Director Institute of Public Health, University of Cologne

• Director WHO Collaborating Center on Evidence Synthesis and Evaluation of Novel Cancer Therapies

• Co-ordinating Editor Cochrane Haematology; University Hospital of Cologne

• Head of Working Group Evidence-based Medicine, Department I of Internal Medicine, University Hospital of Cologne

• Scientific Co-ordinator Standard Operating Procedures, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne 

• Head Cochrane Cancer Network, Cochrane, London, UK 

• Assistant physician general medicine; Dres Rosenthal, Reinecke, Metternich. Cologne

• Deputy head of Clinical Trials Center Cologne, University of Cologne

• Project manager; Clinical Trials Center Cologne, University of Cologne

• Research associate; Cochrane Haematological Malignancies; Department I of Internal Medicine, University Hospital of Cologne

• IT specialist; Bayer AG, Leverkusen, Germany

2020 

• Professor, University of Cologne

• Habilitation and venia legendi for Theoretical Medicine, University of Cologne

• Doctorate at the Institute of Psychosomatics and Psychotherapy, University of Cologne

• Study of Medicine at the University of Cologne (incl. parental leave)

• Training to computer scientist at Bayer AG, Leverkusen, Germany

• David-Sackett Prize, Network Evidence-based Medicine, Germany

• Bill Silverman Prize, Cochrane 

• Member Steering Group Network Evidence-based Medicine, Germany 

• Member Steering Group GRADE Guidance Group

• Member WHO Cancer Essential Medicines List Working Group

• Member Steering Group Living Evidence Network 

• Member Editorial Board; Cochrane

• Member Implementation of Prognosis Reviews Group; Cochrane